AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 171 min read$PATH

Malpani Raghavendra sold $1.4M of PATH

Malpani Raghavendra (CPO & CTO) sold 98,429 shares of UiPath, Inc. (PATH) at $13.81 ($1.36M total) on 2026-09-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Malpani Raghavendra
Published Sep 17, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PATH
Bearish
medium confidence
Mentioned
$PATH
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PATHBearishMed
01

Why it matters

The disclosed sale provides fresh data on insider activity, which can be factored into short‑term trading decisions.

02

Market read

New Form 4 filing reveals insider sell‑off, offering a modest trading signal for PATH.

03

What to watch

Potential upcoming earnings or product announcements could offset any negative sentiment from the insider sale.

Relevance 5/10Novelty 7/10Timing: post‑market 2026‑09‑16

Background

UiPath is a leading provider of robotic process automation software. Insider transactions are disclosed via Form 4 filings.

Company-level read

Ticker impact

$PATHBearishMedium confidence
Context

CPO & CTO Malpani Raghavendra sold 98,429 shares of UiPath for $1.36M via a 10b5‑1 plan.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

The sale size is notable for an executive but not large enough to cause a major move; market may react negatively to insider selling.

Market effects

Sector

Minimal impact on the broader RPA/software sector; insider sales are common and unlikely to shift sector sentiment.

Regional

US market only; no regional effect.

Global

Low; limited to UiPath investors.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to company outlook; price may remain stable.

Key entities

  • Company
    UiPath, Inc.

    Publicly traded RPA software provider (ticker PATH).

  • Executive
    Malpani Raghavendra

    Chief Product Officer & Chief Technology Officer of UiPath.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PATH insider trading history →

Related articles

SEP 30
$PATHMed

UiPath Stock Steadies As AI Agent Push Meets Wall Street Caution

UiPath Inc. (NYSE: PATH) shares rose 4.5% on September 30, 2026, driven by strong enterprise automation adoption and AI growth sentiment. The stock has been trading between $12.60 and $13.00, showing signs of stabilization. UiPath reported quarterly revenue of $410.3M, gross margin of 82.6%, and net income of $36.1M. The company is shifting focus to AI agents and orchestration, with aggressive long-term targets.

timothysykes.com3 min
SEP 17
$PATHMed

A Philippine Telecom’s AI Makeover Tests UiPath’s (PATH) Pitch

UiPath (PATH) announced that PLDT, a Philippine telecom, scaled its use of UiPath's AI platform, improving efficiency and saving thousands of work hours. PATH reported Q2 2027 revenue of $410M, up 13% YoY, and annual recurring revenue of $1.938B, up 12%. The company also introduced new products and reshuffled its executive team. PATH's net new ARR was $37M, and GAAP operating income was $32M, below non-GAAP figures.

insidermonkey.com3 min